Vivoryon Therapeutics N.V.

VVY.AS · AMS
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€21-€28-€28-€13
Dep. & Amort.€0€0€0€0
Deferred Tax€0€0-€0€3
Stock-Based Comp.€0€4€3€2
Change in WC-€1-€0€0-€1
Other Non-Cash€2€3€3-€3
Operating Cash Flow-€19-€22-€22-€11
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases€0-€19€0€0
Inv. Sales/Matur.€10€9€0€0
Other Inv. Act.€0-€1€0€0
Investing Cash Flow€10-€11-€0-€0
Financing Activities
Debt Repay.-€0-€0-€0-€0
Stock Issued€0€26€36€1
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€0-€2-€3€0
Financing Cash Flow-€0€24€33-€1
Forex Effect€0-€0€0€0
Net Chg. in Cash-€9-€8€12-€12
Supplemental Information
Beg. Cash€19€27€15€26
End Cash€9€19€27€15
Free Cash Flow-€19-€22-€22-€11